 KELOWNA, BC ACCESSWIRE January 15, 2021 Lexaria Bioscience Corp. NASDAQ:LEXXNASDAQ:LEXXWCSE:LXX the Company today announced the closing of its previously announced underwritten public offering the Offering of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of 5.25 per unit all prices in US. The warrants have an exercise price of 6.58 per share, are immediately exercisable and will expire five years following the date of issuance. 